<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2020-10-07" version="217">
<accession>P48023</accession>
<accession>Q9BZP9</accession>
<name>TNFL6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tumor necrosis factor ligand superfamily member 6</fullName>
</recommendedName>
<alternativeName>
<fullName>Apoptosis antigen ligand</fullName>
<shortName>APTL</shortName>
</alternativeName>
<alternativeName>
<fullName>CD95 ligand</fullName>
<shortName>CD95-L</shortName>
</alternativeName>
<alternativeName>
<fullName>Fas antigen ligand</fullName>
<shortName>Fas ligand</shortName>
<shortName>FasL</shortName>
</alternativeName>
<cdAntigenName>CD178</cdAntigenName>
<component>
<recommendedName>
<fullName>Tumor necrosis factor ligand superfamily member 6, membrane form</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Tumor necrosis factor ligand superfamily member 6, soluble form</fullName>
</recommendedName>
<alternativeName>
<fullName>Receptor-binding FasL ectodomain</fullName>
</alternativeName>
<alternativeName>
<fullName>Soluble Fas ligand</fullName>
<shortName>sFasL</shortName>
</alternativeName>
</component>
<component>
<recommendedName>
<fullName>ADAM10-processed FasL form</fullName>
<shortName>APL</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>FasL intracellular domain</fullName>
<shortName>FasL ICD</shortName>
</recommendedName>
<alternativeName>
<fullName>SPPL2A-processed FasL form</fullName>
<shortName>SPA</shortName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">FASLG</name>
<name type="synonym">APT1LG1</name>
<name type="synonym">CD95L</name>
<name type="synonym">FASL</name>
<name type="synonym">TNFSF6</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="J. Exp. Med." volume="181" first="71" last="77">
<title>Fas ligand mediates activation-induced cell death in human T lymphocytes.</title>
<authorList>
<person name="Alderson M."/>
</authorList>
<dbReference type="PubMed" id="7528780"/>
<dbReference type="DOI" id="10.1084/jem.181.1.71"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Int. Immunol." volume="6" first="1567" last="1574">
<title>Human Fas ligand: gene structure, chromosomal location and species specificity.</title>
<authorList>
<person name="Takahashi T."/>
<person name="Tanaka M."/>
<person name="Inazawa J."/>
<person name="Abe T."/>
<person name="Suda T."/>
<person name="Nagata S."/>
</authorList>
<dbReference type="PubMed" id="7826947"/>
<dbReference type="DOI" id="10.1093/intimm/6.10.1567"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="submission" date="1995-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Schaetzlein C.E."/>
<person name="Poehlmann R."/>
<person name="Philippsen P."/>
<person name="Eibel H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="204" first="468" last="474">
<title>Role of Fas ligand in apoptosis induced by hepatitis C virus infection.</title>
<authorList>
<person name="Mita E."/>
<person name="Hayashi N."/>
<person name="Iio S."/>
<person name="Takehara T."/>
<person name="Hijioka T."/>
<person name="Kasahara A."/>
<person name="Fusamoto H."/>
<person name="Kamada T."/>
</authorList>
<dbReference type="PubMed" id="7980502"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.2483"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2000-07" db="EMBL/GenBank/DDBJ databases">
<title>Isolation and characterization of a new naturally occurring variant of human Fas ligand that is expressed only in membrane bound form.</title>
<authorList>
<person name="Zeytun A."/>
<person name="Nagarkatti M."/>
<person name="Nagarkatti P.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Leukocyte</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="1998-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Matsumura M."/>
<person name="Nakanishi Y."/>
<person name="Ohba Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-10</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="J. Clin. Invest." volume="98" first="1107" last="1113">
<title>Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.</title>
<authorList>
<person name="Wu J."/>
<person name="Wilson J."/>
<person name="He J."/>
<person name="Xiang L."/>
<person name="Schur P.H."/>
<person name="Mountz J.D."/>
</authorList>
<dbReference type="PubMed" id="8787672"/>
<dbReference type="DOI" id="10.1172/jci118892"/>
</citation>
<scope>INVOLVEMENT IN ALPS1B</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="18827" last="18833">
<title>Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.</title>
<authorList>
<person name="Schneider P."/>
<person name="Bodmer J.-L."/>
<person name="Holler N."/>
<person name="Mattmann C."/>
<person name="Scuderi P."/>
<person name="Terskikh A."/>
<person name="Peitsch M.C."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="9228058"/>
<dbReference type="DOI" id="10.1074/jbc.272.30.18827"/>
</citation>
<scope>CHARACTERIZATION</scope>
<scope>MUTAGENESIS OF PRO-206; TYR-218 AND PHE-275</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="Nat. Med." volume="4" first="31" last="36">
<title>Downregulation of Fas ligand by shedding.</title>
<authorList>
<person name="Tanaka M."/>
<person name="Itai T."/>
<person name="Adachi M."/>
<person name="Nagata S."/>
</authorList>
<dbReference type="PubMed" id="9427603"/>
<dbReference type="DOI" id="10.1038/nm0198-031"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Cell Death Differ." volume="14" first="1678" last="1687">
<title>The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells.</title>
<authorList>
<person name="Kirkin V."/>
<person name="Cahuzac N."/>
<person name="Guardiola-Serrano F."/>
<person name="Huault S."/>
<person name="Luckerath K."/>
<person name="Friedmann E."/>
<person name="Novac N."/>
<person name="Wels W.S."/>
<person name="Martoglio B."/>
<person name="Hueber A.O."/>
<person name="Zornig M."/>
</authorList>
<dbReference type="PubMed" id="17557115"/>
<dbReference type="DOI" id="10.1038/sj.cdd.4402175"/>
</citation>
<scope>FUNCTION OF FASL INTRACELLULAR DOMAIN</scope>
<scope>CLEAVAGE BY ADAM10 AND SPPL2A</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="J. Cell Sci." volume="120" first="191" last="199">
<title>Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation.</title>
<authorList>
<person name="Zuccato E."/>
<person name="Blott E.J."/>
<person name="Holt O."/>
<person name="Sigismund S."/>
<person name="Shaw M."/>
<person name="Bossi G."/>
<person name="Griffiths G.M."/>
</authorList>
<dbReference type="PubMed" id="17164290"/>
<dbReference type="DOI" id="10.1242/jcs.03315"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH FGR; FYN AND LYN</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="BMC Immunol." volume="10" first="53" last="53">
<title>Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.</title>
<authorList>
<person name="Voss M."/>
<person name="Lettau M."/>
<person name="Janssen O."/>
</authorList>
<dbReference type="PubMed" id="19807924"/>
<dbReference type="DOI" id="10.1186/1471-2172-10-53"/>
</citation>
<scope>INTERACTION WITH ARHGAP9; BAIAP2L1; BTK; CACNB3; CACNB4; CRK; DLG2; DNMBP; DOCK4; EPS8L3; FYB1; FYN; HCK; ITK; ITSN2; KALRN; LYN; MACC1; MIA; MPP4; MYO15A; NCF1; NCK1; NCK2; NCKIPSD; OSTF1; PIK3R1; PSTPIP1; RIMBP3C; SAMSN1; SH3GL3; SH3PXD2B; SH3PXD2A; SH3RF2; SKAP2; SNX33; SNX9; SORBS3; SPTA1; SRC; SRGAP1; SRGAP2; SRGAP3; TEC; TJP3 AND YES1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2016" name="Structure" volume="24" first="2016" last="2023">
<title>Crystal structure of the complex of human FasL and its decoy receptor DcR3.</title>
<authorList>
<person name="Liu W."/>
<person name="Ramagopal U."/>
<person name="Cheng H."/>
<person name="Bonanno J.B."/>
<person name="Toro R."/>
<person name="Bhosle R."/>
<person name="Zhan C."/>
<person name="Almo S.C."/>
</authorList>
<dbReference type="PubMed" id="27806260"/>
<dbReference type="DOI" id="10.1016/j.str.2016.09.009"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 130-281 IN COMPLEX WITH TNFRSF6B</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>GLYCOSYLATION</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2015" name="Pediatr. Res." volume="78" first="603" last="608">
<title>Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.</title>
<authorList>
<person name="Ruiz-Garcia R."/>
<person name="Mora S."/>
<person name="Lozano-Sanchez G."/>
<person name="Martinez-Lostao L."/>
<person name="Paz-Artal E."/>
<person name="Ruiz-Contreras J."/>
<person name="Anel A."/>
<person name="Gonzalez-Granado L.I."/>
<person name="Moreno-Perez D."/>
<person name="Allende L.M."/>
</authorList>
<dbReference type="PubMed" id="26334989"/>
<dbReference type="DOI" id="10.1038/pr.2015.170"/>
</citation>
<scope>VARIANT ALPS1B SER-202</scope>
<scope>CHARACTERIZATION OF VARIANT ALPS1B SER-202</scope>
</reference>
<comment type="function">
<text evidence="3 6 9 10 12 13">Cytokine that binds to TNFRSF6/FAS, a receptor that transduces the apoptotic signal into cells (PubMed:26334989, PubMed:9228058). Involved in cytotoxic T-cell-mediated apoptosis, natural killer cell-mediated apoptosis and in T-cell development (PubMed:9228058, PubMed:7528780, PubMed:9427603). Initiates fratricidal/suicidal activation-induced cell death (AICD) in antigen-activated T-cells contributing to the termination of immune responses (By similarity). TNFRSF6/FAS-mediated apoptosis has also a role in the induction of peripheral tolerance (By similarity). Binds to TNFRSF6B/DcR3, a decoy receptor that blocks apoptosis (PubMed:27806260).</text>
</comment>
<comment type="function">
<molecule>Tumor necrosis factor ligand superfamily member 6, soluble form</molecule>
<text evidence="3 9">Induces FAS-mediated activation of NF-kappa-B, initiating non-apoptotic signaling pathways (By similarity). Can induce apoptosis but does not appear to be essential for this process (PubMed:27806260).</text>
</comment>
<comment type="function">
<molecule>FasL intracellular domain</molecule>
<text evidence="6">Cytoplasmic form induces gene transcription inhibition.</text>
</comment>
<comment type="subunit">
<text evidence="5 7 9 15">Homotrimer (PubMed:27806260). Interacts with ARHGAP9, BAIAP2L1, BTK, CACNB3, CACNB4, CRK, DLG2, DNMBP, DOCK4, EPS8L3, FGR, FYB1, FYN, HCK, ITK, ITSN2, KALRN, LYN, MACC1, MIA, MPP4, MYO15A, NCF1, NCK1, NCK2, NCKIPSD, OSTF1, PIK3R1, PSTPIP1, RIMBP3C, SAMSN1, SH3GL3, SH3PXD2B, SH3PXD2A, SH3RF2, SKAP2, SNX33, SNX9, SORBS3, SPTA1, SRC, SRGAP1, SRGAP2, SRGAP3, TEC, TJP3 and YES1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-78060">
<id>Q14790</id>
<label>CASP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-3867333">
<id>A8MQ03</id>
<label>CYSRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-947964">
<id>Q16610</id>
<label>ECM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-494804">
<id>Q13158</id>
<label>FADD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-494743">
<id>P25445</id>
<label>FAS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-1111248">
<id>Q96RU3</id>
<label>FNBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-8638439">
<id>Q8IYA8</id>
<label>IHO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-968552">
<id>Q08881</id>
<label>ITK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-1049638">
<id>Q14525</id>
<label>KRT33B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-10171697">
<id>Q6A162</id>
<label>KRT40</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-1052037">
<id>Q8IUC1</id>
<label>KRTAP11-1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-11953334">
<id>P60328</id>
<label>KRTAP12-3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-16429340">
<id>A0A0S2Z4D7</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-15578122">
<id>P16333-1</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-713635">
<id>O43639</id>
<label>NCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-945833">
<id>Q7Z3S9</id>
<label>NOTCH2NLA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-721769">
<id>Q9BY11</id>
<label>PACSIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-742503">
<id>Q9UNF0</id>
<label>PACSIN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-77926">
<id>Q9UKS6</id>
<label>PACSIN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-1050964">
<id>O43586</id>
<label>PSTPIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-1052678">
<id>O76081</id>
<label>RGS20</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-10178530">
<id>O76081-6</id>
<label>RGS20</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-81088">
<id>Q15436</id>
<label>SEC23A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-2481535">
<id>Q8WV41</id>
<label>SNX33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-77848">
<id>Q9Y5X1</id>
<label>SNX9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-1051034">
<id>O75044</id>
<label>SRGAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-949753">
<id>Q63HR2</id>
<label>TNS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-739936">
<id>Q15642</id>
<label>TRIP10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-742327">
<id>Q15654</id>
<label>TRIP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-775229">
<id>Q9DBG3</id>
<label>Ap2b1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-495538">
<id>P48023</id>
</interactant>
<interactant intactId="EBI-6879954">
<id>Q91ZR2</id>
<label>Snx18</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="6 13">Cell membrane</location>
<topology evidence="4">Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Cytoplasmic vesicle lumen</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Lysosome lumen</location>
</subcellularLocation>
<text evidence="5 6">Is internalized into multivesicular bodies of secretory lysosomes after phosphorylation by FGR and monoubiquitination (PubMed:17164290). Colocalizes with the SPPL2A protease at the cell membrane (PubMed:17557115).</text>
</comment>
<comment type="subcellular location">
<molecule>Tumor necrosis factor ligand superfamily member 6, soluble form</molecule>
<subcellularLocation>
<location evidence="13">Secreted</location>
</subcellularLocation>
<text evidence="13">May be released into the extracellular fluid by cleavage from the cell surface.</text>
</comment>
<comment type="subcellular location">
<molecule>FasL intracellular domain</molecule>
<subcellularLocation>
<location evidence="6">Nucleus</location>
</subcellularLocation>
<text evidence="6">The FasL ICD cytoplasmic form is translocated into the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P48023-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P48023-2</id>
<name>2</name>
<sequence type="described" ref="VSP_006443 VSP_006444"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="6 13">The soluble form derives from the membrane form by proteolytic processing. The membrane-bound form undergoes two successive intramembrane proteolytic cleavages. The first one is processed by ADAM10 producing an N-terminal fragment, which lacks the receptor-binding extracellular domain. This ADAM10-processed FasL (FasL APL) remnant form is still membrane anchored and further processed by SPPL2A that liberates the FasL intracellular domain (FasL ICD). FasL shedding by ADAM10 is a prerequisite for subsequent intramembrane cleavage by SPPL2A in T-cells.</text>
</comment>
<comment type="PTM">
<text evidence="9 12">N-glycosylated (PubMed:9228058). Glycosylation enhances apoptotic activity (PubMed:27806260).</text>
</comment>
<comment type="PTM">
<text evidence="5">Phosphorylated by FGR on tyrosine residues; this is required for ubiquitination and subsequent internalization.</text>
</comment>
<comment type="PTM">
<text evidence="5">Monoubiquitinated.</text>
</comment>
<comment type="disease" evidence="8 11">
<disease id="DI-00156">
<name>Autoimmune lymphoproliferative syndrome 1B</name>
<acronym>ALPS1B</acronym>
<description>A disorder of apoptosis that manifests in early childhood and results in the accumulation of autoreactive lymphocytes. It is characterized by non-malignant lymphadenopathy with hepatosplenomegaly, and autoimmune hemolytic anemia, thrombocytopenia and neutropenia.</description>
<dbReference type="MIM" id="601859"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the tumor necrosis factor family.</text>
</comment>
<comment type="online information" name="FASLGbase">
<link uri="http://structure.bmc.lu.se/idbase/FASLGbase/"/>
<text>FASLG mutation db</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/FAS_ligand"/>
<text>FAS-ligand entry</text>
</comment>
<dbReference type="EMBL" id="U08137">
<property type="protein sequence ID" value="AAC50071.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U11821">
<property type="protein sequence ID" value="AAC50124.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X89102">
<property type="protein sequence ID" value="CAA61474.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D38122">
<property type="protein sequence ID" value="BAA07320.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288573">
<property type="protein sequence ID" value="AAG60017.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z96050">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017502">
<property type="protein sequence ID" value="AAH17502.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB013303">
<property type="protein sequence ID" value="BAA32542.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1304.1">
<molecule id="P48023-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS76243.1">
<molecule id="P48023-2"/>
</dbReference>
<dbReference type="PIR" id="I38707">
<property type="entry name" value="I38707"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000630.1">
<molecule id="P48023-1"/>
<property type="nucleotide sequence ID" value="NM_000639.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001289675.1">
<molecule id="P48023-2"/>
<property type="nucleotide sequence ID" value="NM_001302746.1"/>
</dbReference>
<dbReference type="PDB" id="1BZI">
<property type="method" value="Model"/>
<property type="chains" value="B/C=1-281"/>
</dbReference>
<dbReference type="PDB" id="4MSV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=130-281"/>
</dbReference>
<dbReference type="PDB" id="5L19">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=130-281"/>
</dbReference>
<dbReference type="PDB" id="5L36">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=130-281"/>
</dbReference>
<dbReference type="PDBsum" id="1BZI"/>
<dbReference type="PDBsum" id="4MSV"/>
<dbReference type="PDBsum" id="5L19"/>
<dbReference type="PDBsum" id="5L36"/>
<dbReference type="SMR" id="P48023"/>
<dbReference type="BioGRID" id="106852">
<property type="interactions" value="91"/>
</dbReference>
<dbReference type="DIP" id="DIP-2997N"/>
<dbReference type="ELM" id="P48023"/>
<dbReference type="IntAct" id="P48023">
<property type="interactions" value="83"/>
</dbReference>
<dbReference type="MINT" id="P48023"/>
<dbReference type="STRING" id="9606.ENSP00000356694"/>
<dbReference type="ChEMBL" id="CHEMBL5714"/>
<dbReference type="GlyGen" id="P48023">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P48023"/>
<dbReference type="PhosphoSitePlus" id="P48023"/>
<dbReference type="SwissPalm" id="P48023"/>
<dbReference type="BioMuta" id="FASLG"/>
<dbReference type="DMDM" id="1345957"/>
<dbReference type="MassIVE" id="P48023"/>
<dbReference type="PaxDb" id="P48023"/>
<dbReference type="PeptideAtlas" id="P48023"/>
<dbReference type="PRIDE" id="P48023"/>
<dbReference type="ProteomicsDB" id="55831">
<molecule id="P48023-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55832">
<molecule id="P48023-2"/>
</dbReference>
<dbReference type="ABCD" id="P48023">
<property type="antibodies" value="4 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="4418">
<property type="antibodies" value="1278 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="356"/>
<dbReference type="Ensembl" id="ENST00000340030">
<molecule id="P48023-2"/>
<property type="protein sequence ID" value="ENSP00000344739"/>
<property type="gene ID" value="ENSG00000117560"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000367721">
<molecule id="P48023-1"/>
<property type="protein sequence ID" value="ENSP00000356694"/>
<property type="gene ID" value="ENSG00000117560"/>
</dbReference>
<dbReference type="GeneID" id="356"/>
<dbReference type="KEGG" id="hsa:356"/>
<dbReference type="UCSC" id="uc001git.4">
<molecule id="P48023-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="356"/>
<dbReference type="DisGeNET" id="356"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000117560.7"/>
<dbReference type="GeneCards" id="FASLG"/>
<dbReference type="GeneReviews" id="FASLG"/>
<dbReference type="HGNC" id="HGNC:11936">
<property type="gene designation" value="FASLG"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000117560">
<property type="expression patterns" value="Tissue enhanced (blood, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="FASLG"/>
<dbReference type="MIM" id="134638">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="601859">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P48023"/>
<dbReference type="OpenTargets" id="ENSG00000117560"/>
<dbReference type="Orphanet" id="3261">
<property type="disease" value="Autoimmune lymphoproliferative syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA56"/>
<dbReference type="eggNOG" id="ENOG502S09I">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214425"/>
<dbReference type="HOGENOM" id="CLU_070352_2_0_1"/>
<dbReference type="InParanoid" id="P48023"/>
<dbReference type="KO" id="K04389"/>
<dbReference type="OMA" id="PQIFWVD"/>
<dbReference type="PhylomeDB" id="P48023"/>
<dbReference type="TreeFam" id="TF332169"/>
<dbReference type="PathwayCommons" id="P48023"/>
<dbReference type="Reactome" id="R-HSA-140534">
<property type="pathway name" value="Caspase activation via Death Receptors in the presence of ligand"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371378">
<property type="pathway name" value="Regulation by c-FLIP"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5213460">
<property type="pathway name" value="RIPK1-mediated regulated necrosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218900">
<property type="pathway name" value="CASP8 activity is inhibited"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69416">
<property type="pathway name" value="Dimerization of procaspase-8"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75157">
<property type="pathway name" value="FasL/ CD95L signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8862803">
<property type="pathway name" value="Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9614657">
<property type="pathway name" value="FOXO-mediated transcription of cell death genes"/>
</dbReference>
<dbReference type="SIGNOR" id="P48023"/>
<dbReference type="BioGRID-ORCS" id="356">
<property type="hits" value="4 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="FASLG">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Fas_ligand"/>
<dbReference type="GenomeRNAi" id="356"/>
<dbReference type="Pharos" id="P48023">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P48023"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P48023">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000117560">
<property type="expression patterns" value="Expressed in granulocyte and 82 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P48023">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P48023">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005901">
<property type="term" value="C:caveola"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060205">
<property type="term" value="C:cytoplasmic vesicle lumen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043202">
<property type="term" value="C:lysosomal lumen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0005125">
<property type="term" value="F:cytokine activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005123">
<property type="term" value="F:death receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005164">
<property type="term" value="F:tumor necrosis factor receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030644">
<property type="term" value="P:cellular chloride ion homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048388">
<property type="term" value="P:endosomal lumen acidification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097191">
<property type="term" value="P:extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008625">
<property type="term" value="P:extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006925">
<property type="term" value="P:inflammatory cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070266">
<property type="term" value="P:necroptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097527">
<property type="term" value="P:necroptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000353">
<property type="term" value="P:positive regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045742">
<property type="term" value="P:positive regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043525">
<property type="term" value="P:positive regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902041">
<property type="term" value="P:regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1903514">
<property type="term" value="P:release of sequestered calcium ion into cytosol by endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070848">
<property type="term" value="P:response to growth factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046666">
<property type="term" value="P:retinal cell programmed cell death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0070231">
<property type="term" value="P:T cell apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00184">
<property type="entry name" value="TNF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.120.40">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR028326">
<property type="entry name" value="FASL"/>
</dbReference>
<dbReference type="InterPro" id="IPR006053">
<property type="entry name" value="TNF"/>
</dbReference>
<dbReference type="InterPro" id="IPR021184">
<property type="entry name" value="TNF_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR006052">
<property type="entry name" value="TNF_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008983">
<property type="entry name" value="Tumour_necrosis_fac-like_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00229">
<property type="entry name" value="TNF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01681">
<property type="entry name" value="FASLIGAND"/>
</dbReference>
<dbReference type="PRINTS" id="PR01234">
<property type="entry name" value="TNECROSISFCT"/>
</dbReference>
<dbReference type="SMART" id="SM00207">
<property type="entry name" value="TNF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49842">
<property type="entry name" value="SSF49842"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00251">
<property type="entry name" value="TNF_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50049">
<property type="entry name" value="TNF_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0202">Cytokine</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Tumor necrosis factor ligand superfamily member 6, membrane form" id="PRO_0000034500">
<location>
<begin position="1"/>
<end position="281"/>
</location>
</feature>
<feature type="chain" description="ADAM10-processed FasL form" id="PRO_0000417152">
<location>
<begin position="1"/>
<end position="129"/>
</location>
</feature>
<feature type="chain" description="FasL intracellular domain" id="PRO_0000416842">
<location>
<begin position="1"/>
<end position="81"/>
</location>
</feature>
<feature type="chain" description="Tumor necrosis factor ligand superfamily member 6, soluble form" id="PRO_0000034501">
<location>
<begin position="130"/>
<end position="281"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="1"/>
<end position="80"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="4">
<location>
<begin position="81"/>
<end position="102"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="103"/>
<end position="281"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="4"/>
<end position="70"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="45"/>
<end position="65"/>
</location>
</feature>
<feature type="site" description="Cleavage; by SPPL2A" evidence="15">
<location>
<begin position="81"/>
<end position="82"/>
</location>
</feature>
<feature type="site" description="Cleavage; by ADAM10" evidence="15">
<location>
<begin position="129"/>
<end position="130"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="184"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="250"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="260"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 9">
<location>
<begin position="202"/>
<end position="233"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_006443" evidence="14">
<original>STSQMHTASSL</original>
<variation>ATPVHPLKKRS</variation>
<location>
<begin position="117"/>
<end position="127"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_006444" evidence="14">
<location>
<begin position="128"/>
<end position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12079514." id="VAR_052583">
<original>Y</original>
<variation>S</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In ALPS1B; significant reduction in cytotoxicity and apoptosis and inhibition of the shedding of the soluble form." id="VAR_075568" evidence="8">
<original>C</original>
<variation>S</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lowers binding to TNFRSF6 and reduces cytotoxicity more than 100-fold." evidence="12">
<original>P</original>
<variation>D</variation>
<variation>F</variation>
<variation>R</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lowers binding to TNFRSF6 and abolishes cytotoxicity." evidence="12">
<original>Y</original>
<variation>F</variation>
<variation>R</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to TNRFSF6 and cytotoxicity." evidence="12">
<original>F</original>
<variation>L</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="137"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="146"/>
<end position="151"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="165"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="170"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="187"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="207"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="218"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="222"/>
<end position="229"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="239"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="256"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="264"/>
<end position="266"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="271"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="274"/>
<end position="280"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MSV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5L19"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P41047"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17164290"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17557115"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19807924"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26334989"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27806260"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7528780"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8787672"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9228058"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9427603"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<sequence length="281" mass="31485" checksum="A8A6EB358246E9BB" modified="1996-02-01" version="1">MQQPFNYPYPQIYWVDSSASSPWAPPGTVLPCPTSVPRRPGQRRPPPPPPPPPLPPPPPPPPLPPLPLPPLKKRGNHSTGLCLLVMFFMVLVALVGLGLGMFQLFHLQKELAELRESTSQMHTASSLEKQIGHPSPPPEKKELRKVAHLTGKSNSRSMPLEWEDTYGIVLLSGVKYKKGGLVINETGLYFVYSKVYFRGQSCNNLPLSHKVYMRNSKYPQDLVMMEGKMMSYCTTGQMWARSSYLGAVFNLTSADHLYVNVSELSLVNFEESQTFFGLYKL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

